•  

Posts Tagged: St. Michael’s Hospital

Johnson & Johnson Innovation Opens JLABS @ Toronto

TORONTO (May 11, 2016) –  Johnson & Johnson Innovation LLC, today announced the opening of JLABS @ Toronto, a new 40,000-square-foot life sciences incubator, providing entrepreneurs shared lab space and offices, modular lab suites and access to scientific, industry and capital funding experts as they work to build important and successful early-stage companies. The new JLABS facility can accommodate up to 50 start-ups and opens with 22 companies that represent a range of sectors including therapeutics, medical devices and consumer health ... Read more

BlueDot profiled in Toronto Star for anticipating Zika virus spread

BlueDot, a Canadian company that helps decision-makers prepare for and response to infectious disease outbreaks, was profiled in the Toronto Star for their work in tracking the Zika virus. The company, founded by Dr. Kamran Khan, was spun-off from St. Michael's Hospital in partnership with MaRS Innovation. The company raised a Series A with Horzions Ventures in 2015. Here's an excerpt from Kate Allen's article: Wayne Gretzky may be an unlikely inspiration for an infectious disease researcher. Yet here Dr. Kamran Khan is, on ... Read more

Ontario advancing nine medical research projects in cancer, heart disease and sleep apnea to market

Applications for next MSc PoP granting round being accepted until February 25, 2016 TORONTO (January 26, 2016) — Nine Ontario-based medical research projects built on great science with potential for significant economic impact are advancing a step closer to market entry thanks to funding from Ontario Centres of Excellence’s Medical Sciences Proof-of-Principle (MSc PoP) program. The projects range from cancer to heart disease to sleep apnea in children. Applications for the next MSc PoP granting round are open until March 4, 2016. To ... Read more

MaRS Innovation sponsoring Angels’ Den competition

Prima IP co-sponsoring the Ryerson University and St. Michael’s Hospital event When your business demands staying current with the newest inventions springing up across 15 academic members, keeping pace with what’s happening is half the challenge. That’s part of the reason why MaRS Innovation and Prima IP are sponsoring winners of an Angels’ Den competition involving the Institute for Biomedical Engineering, Science and Technology (iBEST). iBEST is a partnership between Ryerson University and St. Michael's Hospital that brings together Ryerson's engineering and science strengths ... Read more

Ontario Government, University of Toronto, and MaRS secure Johnson & Johnson Innovation, JLABS for Toronto – first JLABS Incubator outside of United States

Partners for JLABS @ Toronto include Janssen Inc., MaRS Innovation and seven of MI's 15 member institutions   TORONTO, Sept. 8, 2015 — The Ontario Government, University of Toronto, and MaRS Discovery District (MaRS) today announced a collaboration with Janssen Inc. to launch the successful Johnson & Johnson Innovation, JLABS incubator model in Toronto. This announcement has been covered in the Toronto Star, Metro News Canada, Sing Tao Daily, OurWindsor.ca, FierceBiotech, BioCentury, MedCity News, BioSpace, Biotechnology Focus, Lab Product News, ChinaNews.com, Pan European Networks, Economic ... Read more

BlueDot, formerly BioDiaspora Inc., secures Series A with Horizons Ventures

Toronto-based commercial arm of BioDiaspora research program tracks global spread of infectious diseases in real-time; fourth MI company to reach Series A TORONTO (Dec. 2, 2014) — BlueDot, a Toronto-based social benefit corporation founded by Dr. Kamran Khan, an infectious disease physician and scientist, tracks and predicts the global spread of infectious diseases. Spun off from St. Michael’s Hospital in partnership with MaRS Innovation (and formerly known as BioDiaspora Inc.), BlueDot, has secured a Series A venture capital funding from Horizons Ventures. Funded ... Read more

Tech Transfer Central features MaRS Innovation’s partnership with St. Michael’s Hospital

Tech Transfer Tactics, the monthly newsletter for Tech Transfer Central.com, has published a feature highlighting MaRS Innovation's Technology Transfer & Scouting (MITTS) services to St. Michael's Hospital. The interview explores the increase in disclosures and commercial activity achieved after MaRS Innovation began offering technology transfer services to the hospital, and was triggered by a July profile published on MaRS Innovation's website describing the collaborative working relationship between the two organizations. The interview includes conversations with Sahail Shariff, commercialization manager in the MITTS division, ... Read more

BioDiaspora founder appears on CBC’s “The National” to discuss the Ebola crisis

Dr. Kamran Khan, founder of BioDiaspora, appeared on CBC's "The National" on September 23, 2014, as part of a health panel examining the current state of the Ebola outbreak in west Africa. CBC anchor Peter Mansbridge hosted the discussion. Watch the clip on CBC's website. BioDiaspora, spun off from St. Michael's Hospital in partnership with MaRS Innovation, developed an easy-to-access, web-based solution that generates and communicates customized, actionable intelligence about global infectious disease threats in real-time. (more…) Read more

MaRS Innovation and St. Michael’s Hospital revitalizing commercialization process

For principal investigators, a key component in taking their research ideas from the bench to the market is knowing what commercialization resources exist and when to use them. Through the MaRS Innovation's Technology Transfer & Scouting division (MITTS), manager Sahail Shariff is connecting with principal investigators (PIs) at St. Michael's Hospital in Toronto on the front-line to better understand and advance their research. Of the 180 PIs at the hospital, the majority are clinician scientists who spend a portion of their time caring for patients. In collaboration ... Read more

BioDiaspora predicts Hajj and Umrah as two key possible spread points for MERS coronavirus

BioDiaspora, a start-up company based on the research of company founder, Dr. Kamran Khan of St. Michael's Hospital, has identified two mass gatherings in the Islamic world as key possible spread points for the life-threatening MERS coronavirus, which emerged in the Middle East in early 2012. BioDiaspora's disease-tracking platform, which correlates uses global air traffic patterns to predict the international spread of infectious disease (as described in the original media release from St. Michael's Hospital): The first is umrah, a pilgrimage that can ... Read more
Page 1 of 212